Skip to main content
Log in

Structure-activity relationship in Β-carboline derivatives. Molecular structure of Inkasan

  • Molecular Biological Problems in Drug Design and Study of their Mechanism of Action
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literature cited

  1. N. A. Avdulov and N. I. Maisov, Byull. éksp. Biol., No. 11, 564–566 (1981).

    Google Scholar 

  2. N. I. Andreeva, R. G. Glushkov, and M. D. Mashkovskii, Khim. farm. Zh., No. 4, 111–114 (1979).

    Google Scholar 

  3. N. I. Andreeva and M. D. Mashkovskii, Farmakol. Toksikol., No. 2, 133–137 (1980).

    Google Scholar 

  4. L. G. Vasil'evykh, R. G. Glushkov, V. Z. Gorkin, et al., Khim.-farm. Zh., No. 7, 20–24 (1979).

    Google Scholar 

  5. I. V. Verevkina, V. V. Asnina. V. Z. Gorkin, and M. D. Mashkovskii, Vopr. Med. Khim., No. 5. 18–123 (1983).

    Google Scholar 

  6. E. M. Gankina, T. A. Moskvitina, V. Z. Gorkin, A. V. Val'dman, Byul. éksp. Biol. No. 11, 29–31 (1982).

    Google Scholar 

  7. R. G. Glushkov, L. G. Vasil'evykh, Z. S. Kagan, and V. Z. Gorkin, Khim.-farm. Zh., No. 5, 58–62 (1981).

    Google Scholar 

  8. G. G. Dvoryantseva. T. N. Ul'yanova, L. B. Altukhova, et al., in: All-Union Symposium on Hydrogen Bond. Summaries of Lectures [in Russian], Kharkov (1977), pp. 103–104.

  9. M. D. Mashkovskii, N. I. Andreeva, and A. I. Polezhaeva, Pharmacology of Antidepressants [in Russian], Moscow (1983)., pp. 158–166.

  10. R. Rein, in: Interatomic Interactions from Diatomics to Biopolymers, B. Pullman, editor, Wiley, New York (1977), pp. 414–488.

    Google Scholar 

  11. R. A. Abramovitch and I. D. Spenser, Adv. Hetrocycl. Chem.,3, 79–207 (1964).

    Google Scholar 

  12. M. M. Airaksinen and I. Kari, Med. Biol.,59, 190–211 (1981).

    Google Scholar 

  13. A. Amit, L. Mester, B. Klewe, and S. Furberg, Acta, Chem. Scand.,A32, 267–270 (1978).

    Google Scholar 

  14. Annual Drug Data Report, Vol. 3, J. R. Prous, editor Barcelona (1981), p. 154.

  15. E. Bayer and G. HÄfelinger, Chem. Ber.,99, 1689–1703 (1966).

    Google Scholar 

  16. N. S. Buckoltz and W. O. Boggan, Biochem. Pharmacol.,26, 1991–1996 (1977).

    Google Scholar 

  17. C. E. Bugg, J. M. Thomas, M. Sundaralingam, and S. T. Rao, Biopolymers,10, 175–219 (1971).

    Google Scholar 

  18. E. Friedman, E. Meller, and M. Hallock, J. Neurochem.,36, 931–937 (1981).

    Google Scholar 

  19. J. Giesecke and H. Hebert, Quart. Rev. Biophys.,12, 263–313 (1979).

    Google Scholar 

  20. R. N. Gupta and I. D. Spenser, Canad. J. Chem.,40. 2049–2056 (1962).

    Google Scholar 

  21. R. Haran, F. Nepveu-Juras, and J.-P. Laurent, Org. Magnet. Reson.,12, 153–158 (1979).

    Google Scholar 

  22. J. R. Ieny, S. R. Zukin, H. M. Praag, Europ. J. Pharmacol.,106, 669–672 (1984).

    Google Scholar 

  23. C. L. Johnson, J. Med. Chem.,19, 600–605 (1976).

    Google Scholar 

  24. H. A. Karapetyan, Yu. T. Struchkov, and G. G. Dvoryantseva, Cryst. Struct. Commun.,11, 1441–1458 (1982).

    Google Scholar 

  25. S. Z. Langer and R. Raisman, Neuropharmacology,22, 407 (1983).

    Google Scholar 

  26. S. Z. Langer, R. Raisman, L. Tahraoui, et al., Europ. J. Pharmacol.,98, 153–154 (1984).

    Google Scholar 

  27. R. Lawaczeck and K. G. Wagner, Biopolymers,13, 2003–2014 (1974).

    Google Scholar 

  28. C. L. Lobenstein-Verbeek, J. A. Jongejian, J. Frank, and J. A. Duine, FEBS Lett.,170, 305–309 (1984).

    Google Scholar 

  29. P. R. Maulic and B. S. Basak, Cryst. Struct. Commun,11, 19–24 (1982).

    Google Scholar 

  30. M. M. McIsaac and V. Estevez, Biochem. Pharmacol.,15, 1625–1627 (1966).

    Google Scholar 

  31. E. Meller, E. Friedman, J. W. Schweitzer, and A. J. Friedhoff, J, Neurochem.,28, 995–1000 (1977).

    Google Scholar 

  32. A. K. Muir and P. W. Cooding, Amer. Cryst. Ass. Ser. 2,11, 30 (1983).

    Google Scholar 

  33. D. L. Nelson, A. Hebert, Y. Petillot, et al., J. Neurochem.,32, 1817–1827 (1979).

    Google Scholar 

  34. M. F. Poirier, H. Loo, C. Benkelfat, et al., Europ. J. Pharmacol.,106, 629–633 (1984).

    Google Scholar 

  35. W. G. Quarles, D. H. Templeton, and A. Zalkin, Acta Crystallogr. Ser. B,30, 95–98 (1974).

    Google Scholar 

  36. R. Raisman, M. S. Briley, and S. Z. Langer, Europe. J. Pharmacol.,61, 373–380 (1980).

    Google Scholar 

  37. R. R. Rando, Pharmacol. Rev.,36, 111–142 (1984).

    Google Scholar 

  38. J. R. Reboul B. Cristau, and J. C. Soyfer, Europe. J. Med. Chem. Chin. Ther.,19, 277–280 (1984).

    Google Scholar 

  39. I. D. Spenser, Canad. J. Chem.,37, 1851–280 (1959).

    Google Scholar 

  40. U. Thewalt and C. E. Bugg, Acta Crystallogr. Ser. B,28, 82–92 (1972).

    Google Scholar 

  41. K. G. Wagner, H. A. Arfman, R. Lawaczeck, et al., in: Nuclear Magnetic Resonance Spectroscopy in Molecular Biology, Vol. 2, Bipullman, editor, Dordrecht (1978), p. 103.

  42. L. D. Wright and D. B. McCormic, Experientia,20, 501–502 (1964).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 19, No. 12, pp. 1424–1434, December, 1985.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dvoryantseva, G.G., Lindeman, S.V., Struchkov, Y.T. et al. Structure-activity relationship in Β-carboline derivatives. Molecular structure of Inkasan. Pharm Chem J 19, 822–831 (1985). https://doi.org/10.1007/BF01148378

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01148378

Keywords

Navigation